Ligand Pharmaceuticals Inc (LGND)
Ligand Pharmaceuticals Market Cap: 1.546B for May 17, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 17, 2024 | 1.546B |
May 16, 2024 | 1.527B |
May 15, 2024 | 1.541B |
May 14, 2024 | 1.532B |
May 13, 2024 | 1.510B |
May 10, 2024 | 1.568B |
May 09, 2024 | 1.547B |
May 08, 2024 | 1.444B |
May 07, 2024 | 1.315B |
May 06, 2024 | 1.308B |
May 03, 2024 | 1.327B |
May 02, 2024 | 1.299B |
May 01, 2024 | 1.283B |
April 30, 2024 | 1.255B |
April 29, 2024 | 1.265B |
April 26, 2024 | 1.267B |
April 25, 2024 | 1.264B |
April 24, 2024 | 1.275B |
April 23, 2024 | 1.255B |
April 22, 2024 | 1.231B |
April 19, 2024 | 1.301B |
April 18, 2024 | 1.300B |
April 17, 2024 | 1.414B |
April 16, 2024 | 1.432B |
April 15, 2024 | 1.430B |
Date | Value |
---|---|
April 12, 2024 | 1.458B |
April 11, 2024 | 1.460B |
April 10, 2024 | 1.448B |
April 09, 2024 | 1.461B |
April 08, 2024 | 1.427B |
April 05, 2024 | 1.397B |
April 04, 2024 | 1.398B |
April 03, 2024 | 1.339B |
April 02, 2024 | 1.312B |
April 01, 2024 | 1.319B |
March 28, 2024 | 1.294B |
March 27, 2024 | 1.262B |
March 26, 2024 | 1.215B |
March 25, 2024 | 1.226B |
March 22, 2024 | 1.257B |
March 21, 2024 | 1.292B |
March 20, 2024 | 1.294B |
March 19, 2024 | 1.278B |
March 18, 2024 | 1.277B |
March 15, 2024 | 1.259B |
March 14, 2024 | 1.274B |
March 13, 2024 | 1.288B |
March 12, 2024 | 1.281B |
March 11, 2024 | 1.279B |
March 08, 2024 | 1.306B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
ANI Pharmaceuticals Inc | 1.288B |
Annovis Bio Inc | 92.84M |
United Therapeutics Corp | 12.17B |
ADMA Biologics Inc | 2.135B |
Blueprint Medicines Corp | 6.572B |
Market Cap Related Metrics
PE Ratio | 16.18 |
PS Ratio | 12.89 |
PEG Ratio | 0.0502 |
Price to Book Value | 1.917 |
Price | 86.06 |
Earnings Yield | 6.18% |
PEGY Ratio | 0.0502 |
Normalized PE Ratio | 268.14 |